Analysts Offer Insights on Healthcare Companies: Knight Therapeutics (Other OTC: KHTRF) and Theratechnologies Inc (Other OTC: THERF)

By Carrie Williams

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Knight Therapeutics (KHTRFResearch Report) and Theratechnologies Inc (THERFResearch Report).

Knight Therapeutics (KHTRF)

Raymond James analyst David Novak maintained a Buy rating on Knight Therapeutics today and set a price target of C$10.25. The company’s shares closed last Monday at $5.57.

According to TipRanks.com, Novak is a 3-star analyst with an average return of 11.1% and a 31.6% success rate. Novak covers the Healthcare sector, focusing on stocks such as Leap Therapeutics Inc, Ziopharm Oncology, and Zymeworks Inc.

Currently, the analyst consensus on Knight Therapeutics is a Strong Buy with an average price target of $7.45.

See today’s analyst top recommended stocks >>

Theratechnologies Inc (THERF)

In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Theratechnologies Inc, with a price target of C$6.00. The company’s shares closed last Monday at $3.79, close to its 52-week low of $3.58.

According to TipRanks.com, Abrahams is a 4-star analyst with an average return of 2.9% and a 45.2% success rate. Abrahams covers the Healthcare sector, focusing on stocks such as Constellation Pharmaceuticals Inc, Proteostasis Therapeutics Inc, and Alder Biopharmaceuticals.

Currently, the analyst consensus on Theratechnologies Inc is a Hold with an average price target of $4.88.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.